Product Information
OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Lannett Company Inc., priced at $0.1496 per ML under NDC 00527513762. Its NADAC has been published 140 times since Jan 31, 2024.
FDA first approved this application on Jan 5, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/mL
Manufacturer
Lannett Company Inc.NDC
00527513762
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA213594FDA Approved
1/5/2022
TE Code
AB
On Market Since
7/13/2023
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 140 times since Jan 31, 2024, and over the history we have for it it has declined 37.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1496 per ML |
|---|---|
| All-time high | $0.2682 (Apr 10, 2024) |
| All-time low | $0.1271 (Nov 20, 2024) |
| 52-week high | $0.1739 |
| 52-week low | $0.1496 |
| Median price | $0.1748 |
| Average price | $0.1834 |
| Largest weekly change | +38.5% (Dec 18, 2024) |
| Weeks tracked | 140 |
| Tracking since | Jan 31, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the oseltamivir phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
oseltamivir phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Lannett Company Inc., is $0.1496 per ML (NDC 00527513762), effective Sep 30, 2026.
How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 37.6%. It has been tracked across 140 weekly CMS publications since Jan 31, 2024.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?
Since Jan 31, 2024, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.2682 (Apr 10, 2024), with a median of $0.1748 per ML.
Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?
OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 00527513762) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.